Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: TPL shares--TPL is not limited--

Feb 23, 2007 05:59AM

Feb 23, 2007 06:06AM
True, no apparent limit on TPL. Also, S&L are TWO different legal entities, most recent 13d/gs show both with 9.99% of float, or 19.98%. And, if S&L are so motivated it is easy in this day of instantaneous global communication to set up additiional legal vehicles to acquire more. Why might they do so with their initial investment of
Share
New Message
Please login to post a reply